13F
中

ARDT ARDENT HEALTH INC

2026Q1 · CUSIP 03980N107 · Sector: Healthcare & Biotech

Neutral · No signal
Holders
135
Δ holders QoQ
+8
Breadth percentile
Top 34%
Whale holders
78
Δ whales
+9
Inst. holding value
$908M
New positions
32
Closed positions
24
Price momentum (1Q)
+3.7%
Put / Call
0/0

Breadth history (34 quarters)

2024Q4: Δ+17 · h=90 2025Q1: Δ+18 · h=108 2025Q2: Δ+3 · h=111 2025Q3: Δ+12 · h=123 2025Q4: Δ+4 · h=127 2026Q1: Δ+8 · h=135 2024Q4: holders=90 2025Q1: holders=108 2025Q2: holders=111 2025Q3: holders=123 2025Q4: holders=127 2026Q1: holders=135 -18 -9 +0 +9 +18 81112142 24Q425Q125Q225Q325Q426Q1 Δ holders (bar) Holders (line)

Past Lit Events & Aftermath 1 lit events

Period Percentile Next-1Q return Next-2Q return
2025Q1 Top 13% -14.7% -45.3%

Options Sentiment

Put holders
0
QoQ: 0
Call holders
0
QoQ: -3

See methodology →

Fundamentals

PE (TTM)
9.9
EPS (TTM)
$0.95
EPS YoY
-42.8%
Revenue (TTM)
$6.4B
Revenue YoY
+6.7%
Quarterly Revenue & EPS (4Y)
2023-06-30: $1.4B 2023-09-30: $1.4B 2024-03-31: $1.4B 2024-06-30: $1.5B 2024-09-30: $1.4B 2024-12-31: $1.6B 2025-03-31: $1.5B 2025-06-30: $1.6B 2025-09-30: $1.6B 2025-12-31: $1.6B 2026-03-31: $1.6B 2023-06-30: EPS 0.26 2023-09-30: EPS 0.17 2024-03-31: EPS 0.21 2024-06-30: EPS 0.34 2024-09-30: EPS 0.19 2024-12-31: EPS 0.84 2025-03-31: EPS 0.29 2025-06-30: EPS 0.52 2025-09-30: EPS -0.17 2025-12-31: EPS 0.32 2026-03-31: EPS 0.28 0B 0.8B 1.6B $B -0.19 0.37 0.92 2023202420252026 Revenue EPS

Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable

P/E (TTM) over time
4Y median 10 2024-06-30: PE 17.32024-09-30: PE 18.32024-12-31: PE 9.32025-03-31: PE 9.32025-06-30: PE 6.82025-09-30: PE 6.12025-12-31: PE 102026-03-31: PE 10.6 5 12 19 2023202420252026

P/E = close 47 days after quarter-end (filing date) ÷ TTM EPS then; loss quarters hidden

As of 2026-03-31 · SEC filings (XBRL)